MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YODA, A.
Right arrow Articles by YODA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YODA, A.
Right arrow Articles by YODA, S.

Molecular Pharmacology, Vol 16, 120-134, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Suppression by Sodium, Potassium or Nucleotides of Binding between Cardiac Steroid (Digoxigenin) and Sodium- and Potassium-Dependent Adenosine Triphosphatase Formed in the Presence of Magnesium and Phosphate

ATSUNOBU YODA 1 and SHIZUKO YODA 1

1 Department of Pharmacology, University of Wisconsin Medical Center, Madison, Wisconsin

The cardiotonic steroid binding to (Na+ + K+)-ATPase formed in the presence of the Mg2+ and Pi (type II binding) is suppressed by the Na+, K+, or nucleotides in different ways. In the ouabain binding at real equilibrium, such effects were difficult to detect because of the high affinity of its sugar moiety to the enzyme. The apparent number of binding sites according to Scatchard plots of digoxigenin binding and the association rate of digoxigenin were reduced by the Na+ at pH 6.5 and 8.5. This Na+-effect was delayed in the initial phase at pH 6.5, when the Na+ was added after the phosphorylation of the enzyme was accomplished by the Mg2+ and Pi. Therefore, the Na+ seems to bind with the nonphosphorylated form of the enzyme, and to reduce level of the phosphorylated enzyme, the active form for digoxigenin binding. In contrast to the Na+, the K+ increased the apparent binding constant according to Scatchard plot of digoxigenin binding at pH 6.5 and 8.5; the K+ seems to bind with the phosphorylated form of enzyme, causing the insensitive complex not to bind with digoxigenin. Unlike either the Na+ or K+, triphosphonucleotides suppressed the type II digoxigenin binding only partially. The potencies of ATP and beta,ggr-methylene ATP were similar; both were most potent among the triphosphonucleotides (its half-maximum concentration [unknown] 0.2 mM). GTP and ITP were less potent while AMP was almost ineffective. ADP was as effective as ATP in less than 0.8 mM, but in higher concentrations, ADP increased the inhibition of digoxigenin binding, reducing the increment of the increase, while ATP showed saturation. According to Scatchard plots, ATP decreased only the apparent number of binding sites below pH 8.0, but it increased only the apparent binding constant above pH 8.0. beta,ggr-Methylene ATP reduced the association rate of digoxigenin at pH 7.0 and 8.3, but did not seem to change the level of phosphorylated protein by the Mg2+ and Pi and the dissociation rate of digoxigenin-enzyme complex at both pHs. Therefore, such nucleotide-effect seems to be one of the low-affinity effects of ATP, and seems to include some conformational changes of phosphorylated active form produced by the Mg2+ and Pi, reducing its affinity to cardiotonic steroids.

Submitted on July 24, 1978
Accepted on January 2, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics